KALA BIO, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
KALA BIO, INC. (KALA) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value of $2.88 million as of 2017-12-31, per its 10-K filed 2019-03-12.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2019-03-12
- 2017-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $2.88M.
- 2017-09-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $2.88M.
- 2017-07-25: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $2.88M.
- 2017-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $2.26M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value as first filed |
|---|---|---|
| 2017-12-31 | $2.88M 10-K · filed 2019-03-12 | |
| 2017-09-30 | $2.88M 10-Q · filed 2018-11-08 | |
| 2017-07-25 | $2.88M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $2.26M 10-Q · filed 2018-11-08 | |
| 2017-03-31 | $1.07M 10-Q · filed 2018-08-09 | |
| 2016-12-31 | $1.04M 10-K · filed 2019-03-12 | |
| 2016-09-30 | $759.00K 10-Q · filed 2017-11-07 | |
| 2016-06-30 | $965.00K 10-Q · filed 2017-08-31 | |
| 2016-03-31 | $965.00K 10-Q · filed 2017-11-07 | $918.00K 10-Q · filed 2017-08-31 |
| 2015-12-31 | $936.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |